학술논문

Safety and clinical activity of subcutaneously (SC) administered anti-PD-1 antibody PF-06801591 in phase I dose-expansion cohorts of locally advanced or metastatic non-small cell lung cancer (NSCLC) and urothelial carcinoma (UC)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; OCT 2019, 30 2p. Supplement: 5
Subject
Language
English
ISSN
15698041